Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z4RZ
|
||||
Former ID |
DNC013797
|
||||
Drug Name |
Adamant-1-ylcarbamic Acid Biphenyl-3-yl Ester
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529498] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H25NO2
|
||||
Canonical SMILES |
C1C2CC3CC1CC(C2)(C3)NC(=O)OC4=CC=CC(=C4)C5=CC=CC=C5
|
||||
InChI |
1S/C23H25NO2/c25-22(24-23-13-16-9-17(14-23)11-18(10-16)15-23)26-21-8-4-7-20(12-21)19-5-2-1-3-6-19/h1-8,12,16-18H,9-11,13-15H2,(H,24,25)
|
||||
InChIKey |
STNJKWWAIGCDRW-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529498] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.